Sanara MedTech Inc. SMTI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 109.81M | 107.48M | 103.12M | 101.88M | 97.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 109.81M | 107.48M | 103.12M | 101.88M | 97.22M |
| Cost of Revenue | 7.65M | 7.61M | 7.52M | 7.90M | 8.01M |
| Gross Profit | 102.16M | 99.87M | 95.60M | 93.98M | 89.20M |
| SG&A Expenses | 84.44M | 81.47M | 78.72M | 78.86M | 77.55M |
| Depreciation & Amortization | 2.49M | 2.56M | 2.66M | 2.18M | 2.67M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.56M | 96.52M | 93.97M | 92.86M | 92.48M |
| Operating Income | 10.26M | 10.97M | 9.15M | 9.02M | 4.73M |
| Income Before Tax | -286.20K | 625.20K | -393.10K | 1.65M | -2.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.29 | 0.63 | -0.39 | 1.65 | -2.07 |
| Earnings from Discontinued Operations | -31.73M | -34.21M | -37.17M | -39.15M | -7.90M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.60K | 5.60K | 5.40K | 5.20K | 29.50K |
| Net Income | -32.02M | -33.58M | -37.56M | -37.49M | -9.94M |
| EBIT | 10.26M | 10.97M | 9.15M | 9.02M | 4.73M |
| EBITDA | 12.80M | 13.58M | 11.86M | 11.25M | 7.40M |
| EPS Basic | -3.71 | -3.89 | -4.35 | -4.34 | -1.16 |
| Normalized Basic EPS | 0.11 | 0.18 | 0.11 | 0.16 | -0.07 |
| EPS Diluted | -3.60 | -3.78 | -4.24 | -4.23 | -1.16 |
| Normalized Diluted EPS | 0.11 | 0.18 | 0.10 | 0.15 | -0.07 |
| Average Basic Shares Outstanding | 34.49M | 34.44M | 34.30M | 34.36M | 34.23M |
| Average Diluted Shares Outstanding | 35.06M | 35.33M | 34.91M | 34.97M | 34.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |